MedPage Today July 12, 2019
Staff

“We’ve waited for decades for this to mature,” said Steven Nissen, MD

In this exclusive MedPage Today video, Steven Nissen, MD, of the Cleveland Clinic, joined us at the recent American College of Cardiology meeting in New Orleans to share his excitement for the potential of continuous glucose monitoring as a method for reducing cardiovascular risk.

Following is a transcript of his remarks:

I’m personally very excited about continuous glucose monitoring, and I’m particularly excited that we’re now seeing the first of a generation of closed-loop systems where there’s actually an adjustment of insulin dosage based upon real-time data with respect to blood glucose. We’ve waited for decades for this to mature and there are several things to think...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Apps, Digital Health, Health System / Hospital, mHealth, Patient / Consumer, Physician, Primary care, Provider, Technology, Wearables
March Fundraising Roundup: 7 Provider Tech Startups That Closed Rounds This Month
Pelago Defies Digital Health Funding Drought, Raises $58M
Digital health venture capital deals stagnate
Finger on the Pulse: The State of Primary Care in the U.S. and Nine Other Countries
Embracing digital transformation with a digital factory

Share This Article